Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Seeff

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Viral Hepatitis|January 11, 2008
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapyJ W Mosley, E A Operskalski, L H Tobler, et al.
Human Pathology|January 1, 1990
Histopathologic analysis of suspected amiodarone hepatotoxicityJ H Lewis, F Mullick, K G Ishak, et al.
The New England Journal of Medicine|October 21, 1976
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposureH J Alter, L B Seeff, P M Kaplan, et al.
American Journal of Epidemiology|April 11, 2001
Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troopsK C Hyams, J Riddle, M Rubertone, et al.
Annals of Internal Medicine|January 22, 2000
45-year follow-up of hepatitis C virus infection in healthy young adultsL B Seeff, R N Miller, C S Rabkin, et al.
The New England Journal of Medicine|April 16, 1987
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States ArmyL B Seeff, G W Beebe, J H Hoofnagle, et al.
The New England Journal of Medicine|December 31, 1992
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study GroupL B Seeff, Z Buskell-Bales, E C Wright, et al.
Gastroenterology|January 1, 1977
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative studyL B Seeff, H J Zimmerman, E C Wright, et al.
Lancet (London, England)|November 15, 1975
Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative StudyL B Seeff, E C Wright, J D Finkelstein, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative studyL B Seeff, F B Hollinger, H J Alter, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Viral Hepatitis|January 11, 2008
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapyJ W Mosley, E A Operskalski, L H Tobler, et al.
Human Pathology|January 1, 1990
Histopathologic analysis of suspected amiodarone hepatotoxicityJ H Lewis, F Mullick, K G Ishak, et al.
The New England Journal of Medicine|October 21, 1976
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposureH J Alter, L B Seeff, P M Kaplan, et al.
American Journal of Epidemiology|April 11, 2001
Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troopsK C Hyams, J Riddle, M Rubertone, et al.
Annals of Internal Medicine|January 22, 2000
45-year follow-up of hepatitis C virus infection in healthy young adultsL B Seeff, R N Miller, C S Rabkin, et al.
The New England Journal of Medicine|April 16, 1987
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States ArmyL B Seeff, G W Beebe, J H Hoofnagle, et al.
The New England Journal of Medicine|December 31, 1992
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study GroupL B Seeff, Z Buskell-Bales, E C Wright, et al.
Gastroenterology|January 1, 1977
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative studyL B Seeff, H J Zimmerman, E C Wright, et al.
Lancet (London, England)|November 15, 1975
Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative StudyL B Seeff, E C Wright, J D Finkelstein, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative studyL B Seeff, F B Hollinger, H J Alter, et al.
Pageof 11